Skip to main content
Premium Trial:

Request an Annual Quote

Certara, LabLogic Sign Software Integration Agreement

Premium

Certara and LabLogic Systems have signed an agreement to integrate software products in their portfolios.

Under the contract terms, Certara’s Phoenix WinNonlin pharmacokinetic/pharmacodynamic modeling and non-compartmental analysis product will be integrated with LabLogic’s Debra Laboratory Information Management System (LIMS) solution, which is used to manage data from absorption, distribution, metabolism, and excretion and protein-binding studies.

Huw Loaring, systems director at LabLogic, said in a statement, that the companies decided to integrate their products “in direct response to customer requests. We are always looking for ways to help our pharmaceutical customers to streamline their drug discovery process.”

The combined solution, Certara said, allows customers using Debra LIMS push their data directly into Phoenix WinNonlin. This direct communication “will increase system usability and should also provide quality control benefits,” Daniel Weiner, Certara’s senior vice president and general manager, said in a statement.

LabLogic is managing customer requests for this product integration.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.